trending Market Intelligence /marketintelligence/en/news-insights/trending/YNhOyn8Oj5jKBW_wYWHJMw2 content esgSubNav
In This List

Tandem Diabetes stockholders approve reverse stock split

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Tandem Diabetes stockholders approve reverse stock split

Tandem Diabetes Care, Inc. stockholders approved the implementation of a 1-for-10 reverse stock split of the company's issued and outstanding common stock.

Following the stock split, Tandem's issued and outstanding common stock will be about 5.5 million shares. The company's authorized common shares will remain at 100 million shares.

Tandem's common stock will trade on the Nasdaq Global Market on a split-adjusted basis beginning Oct. 10.

American Stock Transfer & Trust Co. LLC is acting as the exchange agent for the reverse stock split.